Mirum Pharmaceuticals, Inc.: cashflow_investing
| Value | {"amount": 27015000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-03-31 |
| Status | current |
| Entity | Mirum Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1419a4f8-920a-4da5-8250-b504ba2e67e8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001759425-24-000019Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001759425/cashflow-investing/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1419a4f8-920a-4da5-8250-b504ba2e67e8
History
- supersedes {"amount": 42015000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} (evidence 0000950170-23-017879)